Clonal architecture of CXCR4 WHIM-like mutations in Waldenström Macroglobulinaemia

British Journal of Haematology

Volumn 172, Issue 5, 2016, Pages 735-744

  Xu, Lian ^a   Hunter, Zachary R ^a,b   Tsakmaklis, Nicholas ^a   Cao, Yang ^a,b   Yang, Guang ^a,b   Chen, Jie ^a   Liu, Xia ^a,b   Kanan, Sandra ^a   Castillo, Jorge J ^a,b   Tai, Yu Tzu ^a,b   Zehnder, James L ^c   Brown, Jennifer R ^a,b   Carrasco, Ruben D ^a,b   Advani, Ranjana ^d   Sabile, Jean M ^d   Argyropoulos, Kimon ^e   Lia Palomba, M ^e   Morra, Enrica ^f   Trojani, Alessandra ^f   Greco, Antonino ^f   Tedeschi, Alessandra ^f   Varettoni, Marzia ^g,h   Arcaini, Luca ^g,h   Munshi, Nikhil M ^a,b   Anderson, Kenneth C ^a,b   Treon, Steven P ^a,b   more..

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f OSPEDALE NIGUARDA CA GRANDA   (Italy)

^g UNIVERSITY OF PAVIA   (Italy)

^h FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

WHIM; CXCR4; IgM MGUS; Marginal Zone Lymphoma; MYD88 L265P; Waldenstr m macroglobulinaemia

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CXCR4 PROTEIN, HUMAN; IMMUNOGLOBULIN M; MYD88 PROTEIN, HUMAN; MYELOID DIFFERENTIATION FACTOR 88;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CXCR4 GENE; FEMALE; GENE LOCATION; GENE MUTATION; GENE SEQUENCE; GENOMIC INSTABILITY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MALE; MOLECULAR CLONING; MONOCLONAL IMMUNOGLOBULINEMIA; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; RNA SEQUENCE; WALDENSTROEM MACROGLOBULINEMIA; AMINO ACID SUBSTITUTION; BLOOD; DNA SEQUENCE; GENETICS; MARGINAL ZONE LYMPHOMA; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; PROCEDURES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; FEMALE; GENOMIC INSTABILITY; HUMANS; IMMUNOGLOBULIN M; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE; MUTATION; MYELOID DIFFERENTIATION FACTOR 88; POLYMERASE CHAIN REACTION; RECEPTORS, CXCR4; SEQUENCE ANALYSIS, DNA; WALDENSTROM MACROGLOBULINEMIA;

EID: 84958947359     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.13897     Document Type: Article

References (21)

1. Arcaini, L., Varettoni, M., Boveri, E., Orlandi, E., Rattotti, S., Zibellini, S., Merli, M., Lucioni, M., Rizzi, S., Gotti, M., Morello, L., Pascutto, C. & Paulli, M. (2011) Distinctive clinical and histological features of Waldenstrom's Macroglobulinemia and splenic marginal zone lymphoma. Clinical Lymphoma Myeloma Leukemia, 11, 103-105.
2. S338X somatic mutation activates AKT and ERK, and promotes resistance to ibrutinib and other agents used in the treatment of Waldenstrom's Macroglobulinemia. Leukemia, 29, 169-176.
3. Dotta, L., Tassone, L. & Badolato, R. (2011) Clinical and genetic features of Warts, Hypogammaglobulinemia, Infections and Myelokathexis (WHIM) syndrome. Current Molecular Medicine, 11, 317-325.
4. Hunter, Z.R., Xu, L., Yang, G., Zhou, Y., Liu, X., Cao, Y., Manning, R.J., Tripsas, C., Patterson, C.J., Sheehy, P. & Treon, S.P. (2014) The genomic landscape of Waldenstöm's Macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis. Blood, 123, 1637-1646.
5. Jiménez, C., Sebastián, E., Chillón, M.C., Giraldo, P., Mariano Hernández, J., Escalante, F., González-López, T.J., Aguilera, C., de Coca, A.G., Murillo, I., Alcoceba, M., Balanzategui, A., Sarasquete, M.E., Corral, R., Marín, L.A., Paiva, B., Ocio, E.M., Gutiérrez, N.C., González, M., San Miguel, J.F. & García-Sanz, R. (2013) MYD88 L265P is a marker highly characteristic of, but not restricted to Waldenström's macroglobulinemia. Leukemia, 27, 1722-1728.
6. Kyrtsonis, M.C., Levidou, G., Korkolopoulou, P., Koulieris, E., Bartzi, V., Maltezas, D., Pangalis, G.A., Kalpadakis, C., Dimou, M., Georgiou, G., Vassilakopoulos, T.P., Angelopoulou, M.K., Salpeas, V., Tsaftaridis, P., Patsouris, E., Panayiotidis, P. & Tzenou, T.K. (2011) CD138 expression helps distinguish Waldenstrom's macroglobulinemia from splenic marginal zone lymphoma. Clinical Lymphoma Myeloma Leukemia, 11, 99-102.
7. Landgren, O. & Staudt, L. (2012) MYD88 L265P somatic mutation in IgM MGUS. New England Journal of Medicine, 367, 2255-2257.
8. Martínez, N., Almaraz, C., Vaqué, J.P., Varela, I., Derdak, S., Beltran, S., Mollejo, M., Campos-Martin, Y., Agueda, L., Rinaldi, A., Kwee, I., Gut, M., Blanc, J., Oscier, D., Strefford, J.C., Martinez-Lopez, J., Salar, A., Sole, F., Rodriguez-Peralto, J.L., Diez-Tascón, C., García, J.F., Fraga, M., Sebastián, E., Alvés, J., Menárguez, J., González-Carreró, J., Casado, L.F., Bayes, M., Bertoni, F., Gut, I. & Piris, M.A. (2014) Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation. Leukemia, 28, 1334-1340.
9. Ngo, H.T., Leleu, X., Lee, J., Jia, X., Melhem, M., Runnels, J., Moreau, A.S., Burwick, N., Azab, A.K., Roccaro, A., Azab, F., Sacco, A., Farag, M., Sackstein, R. & Ghobrial, I.M. (2008) SDF-1/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom macroglobulinemia. Blood, 112, 150-158.
10. Ngo, V.N., Young, R.M., Schmitz, R., Jhavar, S., Xiao, W., Lim, K.H., Kohlhammer, H., Xu, W., Yang, Y., Zhao, H., Shaffer, A.L., Romesser, P., Wright, G., Powell, J., Rosenwald, A., Muller-Hermelink, H.K., Ott, G., Gascoyne, R.D., Connors, J.M., Rimsza, L.M., Campo, E., Jaffe, E.S., Delabie, J., Smeland, E.B., Fisher, R.I., Braziel, R.M., Tubbs, R.R., Cook, J.R., Weisenburger, D.D., Chan, W.C. & Staudt, L.M. (2011) Oncogenically active MYD88 mutations in human lymphoma. Nature, 470, 115-121.
11. Owen, R.G., Treon, S.P., Al-Katib, A., Fonseca, R., Greipp, P.R., McMaster, M.L., Morra, E., Pangalis, G.A., San Miguel, J.F., Branagan, A.R. & Dimopoulos, M.A. (2003) Clinicopathological definition of Waldenström's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenström's Macroglobulinemia. Seminars in Oncology, 30, 110-115.
12. Roccaro, A.M., Sacco, A., Jimenez, C., Maiso, P., Moschetta, M., Mishima, Y., Aljawai, Y., Sahin, I., Kuhne, M., Cardarelli, P., Cohen, L., San Miguel, J.F., Garcia-Sanz, R. & Ghobrial, I.M. (2014) C1013G/CXCR4 acts as a driver mutation of tumour progression and modulator of drug resistance in lymphoplasmacytic lymphoma. Blood, 123, 4120-4131.
13. Schmidt, J., Federmann, B., Schindler, N., Steinhilber, J., Bonzheim, I., Fend, F. & Quintanilla-Martinez, L. (2015) MYD88 L265P and CXCR4 mutations in lymphoplasmacytic lymphoma identify cases with high disease activity. British Journal of Haematology, 69, 795-803.
14. Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J. & Vardiman, J.W. (2008) World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues (4th edn). Lyon, France, IARC Press, pp. 194-195.
15. Treon, S.P., Xu, L., Yang, G., Zhou, Y., Liu, X., Cao, Y., Sheehy, P., Manning, R.J., Patterson, C.J., Tripsas, C., Arcaini, L., Pinkus, G.S., Rodig, S.J., Sohani, A.R., Harris, N.L., Laramie, J.M., Skifter, D.A., Lincoln, S.E. & Hunter, Z.R. (2012) MYD88 L265P somatic mutation in Waldenstrom's macroglobulinemia. New England Journal of Medicine, 2012, 826-833.
16. Treon, S.P., Cao, Y., Xu, L., Yang, G., Liu, X. & Hunter, Z.R. (2014) Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenstrom's Macroglobulinemia. Blood, 123, 2791-2796.
17. Treon, S.P., Tripsas, C.K., Meid, K., Warren, D., Varma, G., Green, R., Argyropoulos, K.V., Yang, G., Cao, Y., Xu, L., Patterson, C.J., Rodig, S., Zehnder, J.L., Aster, J.C., Harris, N.L., Kanan, S., Ghobrial, I.M., Castillo, J.J., Laubach, J.P., Hunter, Z.R., Salman, Z., Li, J., Cheng, M., Clow, F., Graef, T., Palomba, M.L. & Advani, R.H. (2015) Ibrutinib in previously treated patients with Waldenström's Macroglobulinemia. New England Journal of Medicine, 372, 1430-1440.
18. Trøen, G., Warsame, A. & Delabie, J. (2013) CD79B and MYD88 mutations in splenic marginal zone lymphoma. ISRN Oncology, 2013, 252318.
19. Varettoni, M., Arcaini, L., Zibellini, S., Boveri, E., Rattotti, S., Riboni, R., Corso, A., Orlandi, E., Bonfichi, M., Gotti, M., Pascutto, C., Mangiacavalli, S., Croci, G., Fiaccadori, V., Morello, L., Guerrera, M.L., Paulli, M. & Cazzola, M. (2013) Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms. Blood, 121, 2522-2528.
20. Xu, L., Hunter, Z.R., Yang, G., Zhou, Y., Cao, Y., Liu, X., Morra, E., Trojani, A., Greco, A., Arcaini, L., Varettoni, M., Brown, J.R., Tai, Y.T., Anderson, K.C., Munshi, N.C., Patterson, C.J., Manning, R.J., Tripsas, C.K., Lindeman, N.I. & Treon, S.P. (2013) MYD88 L265P in Waldenstrom macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction. Blood, 121, 2051-2058.
21. Xu, L., Hunter, Z.R., Yang, G., Cao, Y., Liu, X., Manning, R., Tripsas, C., Chen, J., Patterson, C.J., Kluk, M., Kanan, S., Castillo, J., Lindeman, N. & Treon, S.P. (2014) Detection of MYD88 L265P in peripheral blood of patients with Waldenström's Macroglobulinemia and IgM Monoclonal Gammopathy by allele-specific PCR. Leukemia, 28, 1698-1704.